Gastrointestinal benefit of dairy ingredients to prevent symptoms of gut infection in healthy adult subjects
- Conditions
- Enterotoxigenic E. coliGut infectionsDiarrheaDairy ingredientsEnterotoxische E. coliDarm infectiesDiarreeZuivel ingredienten
- Registration Number
- NL-OMON22648
- Lead Sponsor
- FrieslandCampina Nederland BV
- Brief Summary
Ten Bruggencate SJ, Frederiksen PD, Pedersen SM, Floris-Vollenbroek EG, Lucas-van de Bos E, van Hoffen E, Wejse PL. Dietary Milk-Fat-Globule Membrane Affects Resistance to Diarrheagenic Escherichia coli in Healthy Adults in a Randomized, Placebo-Controlled, Double-Blind Study. J Nutr 2016;146:249-55<br><br> - Ten Bruggencate SJ, Girard SA, Floris-Vollenbroek EG, Bhardwaj R, Tompkins TA. The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study. Eur J Clin Nutr 2015;69:385-91. <br><br> - Ouwehand AC, ten Bruggencate SJ, Schonewille AJ, Alhoniemi E, Forssten SD, Bovee-Oudenhoven IM. Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection. Br J Nutr. 2014;111(3):465-73. <br><br> - Bovee-Oudenhoven IM, Lettink-Wissink ML, Van Doesburg W, Witteman BJ, Van Der Meer R. Diarrhea caused by enterotoxigenic Escherichia coli infection of humans is inhibited by dietary calcium. Gastroenterology 2003;125: 469–76.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 120
1. Male
2. Age between 18 and 55 years.
1. Acute gastroenteritis in the 2 months prior to inclusion.
2. Any confirmed or suspected immunosuppressive or immunodeficient condition including human
immunodeficiency virus infection (HIV).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main study parameters:<br /><br>-Stool frequency: number of stools per<br>day, recorded in online diary<br /><br>- Diarrhea complaints as measured by GSRS questionnaire (Gastro-intestinal Symptom Rating Scale, domain diarrhea), recorded in online diary<br>
- Secondary Outcome Measures
Name Time Method Secondary parameter:<br /><br>- Stool consistency as measured by Bristol Stool Score (BSS, scale 1-7, recorded in<br>online diary)